Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine Co-administered Intramuscularly With Boostrix® and/or Menactra™ in Healthy Female Subjects Aged 11-18 Years
Brief Summary: Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. Vaccination of pre-teens and adolescents, ideally before sexual debut and thus before exposure to oncogenic HPV, is a rational strategy for prevention of cervical cancer, and so HPV vaccination could complement the existing pre-adolescent/adolescents platform. Therefore, this Phase 3b study is designed to evaluate the safety and immunogenicity of co-administering Boostrix and/or Menactra with GSK Biologicals' HPV vaccine (580299) as compared to the administration of any of the vaccines alone.

The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.


Options:
A: Arm Label: qHPV Vaccine; Type: EXPERIMENTAL; Interventions: Biological: (Gardasil™) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: placebo (unspecified) | Intervention Type: BIOLOGICAL; Name: (Gardasil™) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; Assigned to Arm(s): qHPV Vaccine | Intervention Type: BIOLOGICAL; Name: Comparator: placebo (unspecified); Assigned to Arm(s): Placebo
B: Arm Label: Cervarix + Boostrix/Menactra Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Cervarix + Menactra/Boostrix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Cervarix + Boostrix + Menactra Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Boostrix/Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Menactra/Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM | Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299) | Intervention Type: BIOLOGICAL; Name: Different formulations of GSK Biologicals' HPV vaccine (580299); Assigned to Arm(s): Boostrix/Cervarix Group, Cervarix + Boostrix + Menactra Group, Cervarix + Boostrix/Menactra Group, Cervarix + Menactra/Boostrix Group, Cervarix Group, Menactra/Cervarix Group | Intervention Type: BIOLOGICAL; Name: Menactra TM; Assigned to Arm(s): Boostrix/Cervarix Group, Cervarix + Boostrix + Menactra Group, Cervarix + Boostrix/Menactra Group, Cervarix + Menactra/Boostrix Group, Menactra/Cervarix Group | Intervention Type: BIOLOGICAL; Name: Boostrix TM; Assigned to Arm(s): Boostrix/Cervarix Group, Cervarix + Boostrix + Menactra Group, Cervarix + Boostrix/Menactra Group, Cervarix + Menactra/Boostrix Group
C: Arm Label: Gardasil®; Type: EXPERIMENTAL; Interventions: Biological: Gardasil | Arm Label: Cervarix®; Type: EXPERIMENTAL; Interventions: Biological: Cervarix | Intervention Type: BIOLOGICAL; Name: Gardasil; Assigned to Arm(s): Gardasil® | Intervention Type: BIOLOGICAL; Name: Cervarix; Assigned to Arm(s): Cervarix®
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Biological: Cervarix | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo | Intervention Type: BIOLOGICAL; Name: Cervarix; Assigned to Arm(s): A | Intervention Type: BIOLOGICAL; Name: placebo; Assigned to Arm(s): B

Answer: B